Moderna said late Thursday that it has asked the U.S. Food and Drug Administration to approve the emergency use of a second booster of its COVID vaccine for all adults.
In a statement, the company noted its request is based partly on recent data from the United States and Israel showing how well its vaccine protects against the Omicron variant.
Moderna has asked for much broader authorization for a second booster than Pfizer did when it requested FDA emergency use authorization of a second booster of its vaccine for adults 65 and older earlier this week.
